Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

Alexander Laith, Dasha Anderson, Luke Baxter, Matthew D B Claydon, James Rucker, Emma S J Robinson*

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Preclinical models for evaluating psychedelics in the treatment of major depressive disorder'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science